Literature DB >> 28396132

Clostridium difficile infection.

Luis Alcalá Hernández1, Elena Reigadas Ramírez2, Emilio Bouza Santiago3.   

Abstract

Clostridium difficile infection (CDI) is the main cause of nosocomial diarrhea in industrialized countries and the source of a growing number of cases of diarrhea in the community. The outbreak of the hypervirulent strain belonging to ribotype 027 has increased the incidence and severity of CDI in some countries. Although CDI usually courses as a mild diarrhea it can lead to severe forms such as toxic megacolon or septic shock. One of every 2 episodes of CDI is not diagnosed in Spanish hospitals due to a lack of clinical suspicion or the use of insensitive diagnostic methods. The diagnostic techniques of choice are algorithms based on the detection of glutamate dehydrogenase and molecular detection of the genes of the toxins with or without the direct detection of the toxins. The recommended treatment for CDI depends on the type of infection and the characteristics of the patient.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Colitis pseudomembranosa; Fidaxomicina; Fidaxomicine; Metronidazol; Metronidazole; Pseudomembranous colitis; Recurrence; Recurrencia; Vancomicina; Vancomycin

Mesh:

Year:  2017        PMID: 28396132     DOI: 10.1016/j.medcli.2017.01.033

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

Review 1.  Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.

Authors:  I Castro; M Tasias; E Calabuig; M Salavert
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

2.  Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile.

Authors:  Jingpeng Yang; Hong Yang
Journal:  Front Cell Infect Microbiol       Date:  2019-08-07       Impact factor: 5.293

3.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

4.  Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study.

Authors:  E Bouza; J Cobo; M J Rodríguez-Hernández; M Salavert; J P Horcajada; J A Iribarren; E Obi; V Lozano; S Maratia; M Cuesta; E Uría; E Limón
Journal:  Rev Esp Quimioter       Date:  2021-02-23       Impact factor: 1.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.